MedTrace Logo

Dark Halo and MNV: a Study Between ICGA and OCTA

NCT05108285 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-11-17

No results posted yet for this study

Summary

The aim of study is to compare the evaluation of dark halo area of macular neovascularization (MNV) between indocyanine green angiography (ICGA) and optical coherence tomography angiography (OCTA) in order to identify OCTA as effective and useful biomarker in MNV

Conditions

  • Macular Neovascularisation

Interventions

DIAGNOSTIC_TEST

Optical Coherence Tomography Angiography (OCTA) and indocyanine green angiography (ICGA)

OCTA and ICGA is able to detect the dark halo as a area of reduced perfusion around MVN

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Principal Investigators

  • Gilda Cennamo · Università Federico II

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-12-01
Completion
2020-12-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05108285 on ClinicalTrials.gov